Factors influencing the bioavailability of peroral formulations of drugs for dogs

Veterinary Research Communications

Volumn 23, Issue 7, 1999, Pages 425-447

  Sabnis, S ^a  

^a ZOETIS   (United States)

Author keywords

Absorption; Bioavailability; Dog; Elimination; Intestine; Oral administration; Stomach

Indexed keywords

CIPROFIBRATE; DIMPYLATE; DOPAMINE; ENROFLOXACIN; IDAZOXAN; LACIDIPINE; MOSAPRIDE CITRATE; NAFTOPIDIL; NALBUPHINE; NALTREXONE; NOMIFENSINE; PETHIDINE; SALICYLAMIDE; THEOPHYLLINE; THIOBARBITURIC ACID;

ANIMAL EXPERIMENT; CHIRALITY; CIRCADIAN RHYTHM; COMPLEX FORMATION; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DIET; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG ELIMINATION; DRUG FORMULATION; DRUG GRANULE; EMULSION; ENTERIC COATED TABLET; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; REVIEW; STOMACH EMPTYING; STOMACH PH; SUSPENSION; SUSTAINED RELEASE PREPARATION; TABLET FORMULATION;

ADMINISTRATION, ORAL; AGE FACTORS; ANIMAL FEED; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CIRCADIAN RHYTHM; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; FEMALE; HYDROGEN-ION CONCENTRATION; INTESTINAL ABSORPTION; INTESTINE, SMALL; MALE; SEX FACTORS; STEREOISOMERISM; VETERINARY DRUGS;

ANIMALIA; CANIS FAMILIARIS;

EID: 0032730046     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006321625243     Document Type: Review

References (136)

1. Abramson, F., 1988. The effect of induction with phenobarbital on the kinetics and bioavailability of antipyrine in the dog. European Journal of Drug Metabolism and Pharmacokinetics, 13, 123-127
2. Adusumalli, V., Wichmann, J., Wong, K., Kucharczyk, N. and Sofia, R., 1992. Pharmacokinetics of felbamate in pediatric and adult beagle dogs. Epilepsia, 33, 955-960
3. Adusumalli, V., Wichmann, J., Wong, K., Kucharczyk, N. and Sofia, R., 1993. Pharmacokinetics of the new antiasthma and antiallergy drug, azelastine, in pediatric and adult beagle dogs. Biopharmaceutics and Drug Disposition, 14, 233-244
4. Albers, E. and Müller, B., 1995. Cyclodextrin derivatives in pharmaceutics. Critical Reviews in Therapeutics and Drug Carrier Systems, 12, 311-337
5. Argenzio, R., 1984. Digestion, absorption and metabolism. In: M.J. Swenson (ed.), Dukes' Physiology of Domestic Animals, 10th edn, (Cornell University Press, New York), 262-277
6. Arrioja-Dechert, A. (ed.), 1998. Compendium of Veterinary Products, CD 1st edn, (North American Compendiums, Port Huron, Michigan)
7. Augsburger, L., 1996. Hard and soft shell capsules. In: G. Banker and C. Rhodes (eds), Modern Pharmaceutics, 3rd edn, (Marcel Dekker, New York), 395-440
8. Aungst, B., Lam, G. and Sheeter, E., 1985. Oral and rectal nalbuphine bioavailability: first-pass metabolism in rats and dogs. Biopharmaceutics and Drug Disposition, 6, 413-421
9. Baggot, J. and Brown, S., 1998. Basis for selection of the dosage form. In: G. Hardee and J. Baggot (eds), Development and Formulation of Veterinary Dosage Forms, 2nd edn, (Marcel Dekker, New York), 7-143
10. 1-Acid glycoprotein and serum binding of drugs in healthy and diseased dogs. Journal of Veterinary Pharmacology and Therapeutics, 10, 43-48
11. Bialer, M., Batra, V., Morrison, J., Silber, B., Look, Z. and Yacobi, A., 1987. Dose-dependent pharmacokinetics of a new oral cephalosporin, cefixime in the dog. Pharmaceutical Research, 4, 33-37
12. Block, L.H., 1992. On the problem of bioequivalence of drug delivery systems. Memoirs of the Faculty of Pharmaceutical Sciences of Kobe-Gakuin University, 4, 1-21
13. Bodin, N., Ekstrom, B., Forsgren, U., Jalar, L., Magni, L., Ramsay, C. and Sjoberg, B., 1975. Bacampicillin: a new orally well absorbed derivative of ampicillin. Antimicrobial Agents and Chemotherapy, 8, 518-525
14. Brewster, M., Anderson, W., Meinsma, D., Moreno, D., Webb, A., Pablo, L., Estes, K., Derendorf, H., Bodor, N., Sawchuk, R., Cheung, B. and Pop, E., 1997. Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl-β-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions. Journal of Pharmaceutical Sciences, 86, 335-339
15. Brocks, D., Jamali, F. and Russell, A., 1991. Stereoselective disposition of etodolac enantiomers in synovial fluid. Journal of Clinical Pharmacology, 31, 741-746
16. Cartwright, A.C., Brikett, D., Boo, E., McGilveray, D. and eighteen others, 1991. 'International harmonization and consensus DIA meeting on bioavailability and bioequivalence testing requirements and standards'. Drug Information Journal, 25, 471-482
17. Cester, C. and Toutain, P., 1997. A comprehensive model for enrofloxacin to ciprofloxacin transformation and disposition in dog. Journal of Pharmaceutical Sciences, 86, 1148-1155
18. Chapron, D., Korman, L. and Barry, W., 1994. Gastric retention of enteric-coated magnesium chloride tablets. Annals of Pharmacotherapy, 28, 874-877
19. Charman, W., 1997. Lipids, lymph and lipid formulations. Bulletin - Technique Gattefosse, 90, 27-33
20. Charman, W., 1998. Lipids and oral bioavailability: are there yet-to-be realized opportunities? Bulletin -Technique Gattefosse, 91, 55-63
21. Davis, S., Hardy, J. and Fara, J., 1986. Transit of pharmaceutical dosage forms through the small intestine. Gut, 27, 886-892
22. Davis, S., Washington, N., Parr, G., Short, A., John, V., Lloyd, P. and Walker, S., 1988. Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy. British Journal of Clinical Pharmacology, 26, 435-443
23. Debas, H., Yamagashi, T. and Dryburgh, J., 1977. Motilin enhances gastric emptying of liquids in dogs. Gastroenterology, 73, 777-780
24. Delatour, P., Benoit, E., Bourdin, M., Gobron, M. and Moysan, F., 1993. Enantioselectivity in the disposition of the nonsteroidal anti-inflammatory drugs ketoprofen and carprofen in man and animals. Bulletin de l'Académie Nationale de Médecine, 177, 515-527
25. Deppermann, K. and Lode, H., 1993. Fluoroquinolones: interaction profile during enteral absorption. Drugs, 45 (supplement 3), 65-72
26. Dressman, J., 1986. Comparison of canine and human gastrointestinal physiology. Pharmaceutical Research, 3, 123-131
27. Duddu, S., Vakilynejad, M., Jamali, F. and Grant, D., 1993. Stereoselective dissolution of propranolol hydrochloride from hydroxypropyl methylcellulose matrices. Pharmaceutical Research, 10, 1648-1653
28. Dvorchik, B., 1981. Non-human primates as animal models for the study of fetal hepatic drug metabolism. In: L. Soyka and G. Redmond (eds), Drug Metabolism in Immature Human, (Raven Press, New York), 145-162
29. Eckersall, P. and Conner, J., 1988. Bovine and canine acute phase proteins. Veterinary Research Communications, 12, 169-178
30. Elwin, C. and Andersson, S., 1972. Relation between stimulatory effect on gastric acid secretion and antral absorption of chemical compounds. Scandinavian Journal of Gastroenterology, 7, 247-355
31. Emori, H., Yamamoto, K., Yokohama, S. and Nishihata, T., 1995. Bioavailability of Bropirimine 250 mg tablet in dogs: effect of food. Journal of Pharmacy and Pharmacology, 47, 822-826
32. Ensink, J., Klein, W., Mevius, D., Klarenbeek, A. and Vulto, A., 1992. Bioavailability of oral penicillins in the horse: a comparison of pivampicillin and amoxicillin. Journal of Veterinary Pharmacology and Therapeutics, 15, 221-230
33. Fagundes Neto, U., Teichberg, S., Bayne, M. and Lifschitz, F., 1981. Bile salt enhanced rat jejunal absorption of a macromolecular tracer. Pediatric Research, 15, 176
34. Florence, A., 1981. Surfactant interactions with biomembranes and drug absorption. Pure and Applied Chemistry, 53, 2057-2068
35. Gamst, O., 1992. Enteric coated naproxen tablets. European Journal of Rheumatology and Inflammation, 12, 5-8
36. Ganley, J., McEwen, J., Calvert, R. and Barker, M., 1984. The effect of in-vivo dispersion and gastric emptying on glibenclamide absorption from a novel, rapidly dissolving capsule formulation. Journal of Pharmacy and Pharmacology, 36, 734-739
37. Gastauer, R., Eltze, M. and Pabst, J., 1979. Bioavailability and elimination of various digoxin preparations in the beagle dog and possible sex dependence. Arzneimittelforschung, 29, 754-757
38. Gault, M., Longerich, L., Loo, J., Ko, P., Fine, A., Vasdev, S. and Dawe, M., 1984. Digoxin biotransformation. Clinical Pharmacology and Therapeutics, 35, 74-82
39. Ghezzi, P., Saccardo, B., Villa, P., Rossi, V., Bianchi, M. and Dinarello, C., 1986. Role of interleukin-1 in the depression of liver drug metabolism by endotoxin. Infection and Immunity, 54, 837-840
40. Gleysteen, J., Sarna, S. and Myrvik, A., 1985. Canine motor activity of stomach and small bowel: the vagus is not the governor. Gastroenterology, 88, 1926-1932
41. Grossman, M. and Konturek, S., 1974. Gastric acid does drive pancreatic bicarbonate secretion. Scandinavian Journal of Gastroenterology, 9, 299-302
42. Hansen, K., Jansen, J., Mengel, H., Christensen, J. and Bundgaard, H., 1992. Enhanced bioavailability of a new class of dopamine δ-1 antagonists following oral administration of their carbamic acid ester prodrugs to dogs. International Journal of Pharmaceutics, 79, 205-212
43. Hebbard, G., Sun, W., Bochner, F. and Horowitz, M., 1985. Pharmacokinetic considerations in gastrointestinal motor disorders. Clinical Pharmacokinetics, 28, 41-66
44. Horowitz, M., 1987. Inhibition of gastric emptying and feeding by fenfluramine. American Journal of Physiology, 252 (2 Pt 2), R433
45. Hussain, M., Koval, C., Myers, M., Shami, E. and Shefter, E., 1987. Improvement of the oral bioavailability of naltrexone in dogs: a prodrug approach. Journal of Pharmaceutical Sciences, 76, 356-358
46. Itoh, Z., Aizawa, I., Takeuchi, S. and Takayanagi, R., 1977. Diurnal changes in gastric motor activity in conscious dogs. American Journal of Digestive Diseases, 22, 117-124
47. Jacknowitz, A., 1987. Food and disease interactions. US Pharmacist, 12, 66-72.
48. Jamali, F., 1992. Stereochemistry and bioequivalence. Journal of Clinical Pharmacology, 32, 930-934
49. Jamali, F., Mehvar, R. and Pasutto, F., 1989. Enantioselective drug action and disposition: therapeutic pitfalls. Journal of Pharmaceutical Science, 78, 695-715
50. Järvinen, T., Järvinen, K., Schwarting, N. and Stella, V., 1995. β-Cyclodextrin derivatives, SBE4-β-CD and HP-β-CD, increase the oral bioavailability of cinnarizine in beagle dogs. Journal of Pharmaceutical Sciences, 84, 295-299
51. Jin, H., Lee, K., Chang, T., Chey, W. and Dubois, A., 1994. Physiological role of cholecystokinin on gastric emptying and acid output in dogs. Digestive Diseases and Sciences, 39, 2306-2314
52. Kaniwa, N., Aoyagi, N., Ogata, H. and Ejima, A., 1988. Gastric emptying rates of drug preparations. I. Effects of size of dosage forms, food and species on gastric emptying rates. Journal of Pharmacobio-Dynamics, 11, 563-570
53. Kelly, K., 1974. Canine gastric motility and emptying: electric, neural, and hormonal controls. In: E. Daniel, J. Gilbert and B. Schofield (eds), Proceedings of the 4th International Symposium on Gastrointestinal Motility, (Michell Press, Vancouver), 463-470
54. Kelly, K., 1980. Gastric emptying of liquids and solids: roles of proximal and distal stomach. American Journal of Physiology, 239, G71-G76
55. Khalafalla, N., Elgholmy, Z. and Khalil, S., 1981. Influence of high fat diet on GI absorption of griseofulvin tablets in man. Der Pharmazie, 36, 692-693
56. Kitani, K., Ohta, M., Kanai, S. and Sato, Y., 1985. Sex difference in the biliary excretion of digoxin and its metabolites in aging Wistar rats. Archives of Gerontology and Geriatrics, 4, 1-12
57. Koj, A., 1996. Initiation of acute phase response and synthesis of cytokines. Biochimica et Biophysica Acta, 1317, 84-94
58. Küng, K. and Wanner, M., 1994. Bioavailability of different forms of amoxycillin administered orally to dogs. Veterinary Record, 135, 552-554
59. Küng, K., Hauser, B. and Wanner, M., 1995. Effect of the interval beteen feeding and drug administration on oral ampicillin absorption in dogs. Journal of Small Animal Practice, 36, 65-68
60. Kushner, I. and Mackiewicz, A., 1993. The acute phase response: an overview. In: A. Mackiewicz, I. Kushner and H. Baumann (eds), Acute Phase Proteins, (CRC Press, Boca Raton, FL), 3-19
61. Lafontaine, M., Cadiere, G., Woussen-Colle, M. and DeGraef, J., 1983. Role of secretin in the control of gastric secretion and emptying in the dog. Archives Internationales de Physiologie et de Biochimie, 91, 459-463
62. Lai, C., Moore, P., Matier, W. and Quon, C., 1987. Comparative pharmacokinetics and bioavailability of phenytoin after oral phenytoin sodium capsule and i.m. injection and oral capsule of a prodrug of phenytoin, ACC-9653, in dogs. Pharmaceutical Research, 4 (supplement), S118
63. Landoni, M., Soraci, A., Delatour, P. and Lees, P., 1997. Enantioselective behavior of drugs used in domestic animals: a review. Journal of Veterinary Pharmacology and Therapeutics, 20, 1-16
64. Langguth, P., Lee, K., Spahn-Langguth, H. and Amidon, G., 1994. Variable gastric emptying and discontinuities in drug absorption profiles: dependence of rates and extent of cimetidine absorption on motility phase and pH. Biopharmaceutics and Drug Disposition, 15, 719-746
65. Larsson, H., Carlsson, E., Junggren, U., Olbe, L., Sjöstrand, S., Skánberg, I. and Sundell, G., 1983. Inhibition of gastric acid secretion by omeprazole in the dog and rat. Gastroenterology, 85, 900-907
66. Leesman, G., Sinko, P. and Amidon, G., 1988. Simulation of oral drug absorption: gastric emptying and gastrointestinal motility. In: P. Welling and F. Tse (eds), Pharmacokinetics, (Marcel Dekker, New York), 267-284
67. Lenz, H., 1988. CNS regulation of gastric and autonomic functions in dogs by gastrin-secreting peptide. American Journal of Physiology, 255, G298-G303
68. Lenz, H., 1989. Neuroendocrine regulation of canine gastric secretion, emptying and blood flow. Journal of Neuroendocrinology, 1, 163-167
69. Li, H., Zhao, S., Wang, N. and Ge, Z., 1996. Pharmacokinetics of naltrexone hydrochloride and naltrexone glucuronide in the dog (in Chinese). Yao Hsueh Hsueh Pao, 31, 254-257
70. Lindberg, R., Sellman, R. and Iisalo, E., 1985. First-pass metabolism of nomifensine in dogs. European Journal of Drug Metabolism and Pharmacokinetics, 10, 21-25
71. Lipka, E., Lee, I., Langguth, P., Spahn-Langguth, H., Mutschler, E. and Amidon, G., 1995. Celiprolol double-peak occurrence and gastric motility: nonlinear mixed effects modelling of bioavailability data obtained in dogs. Journal of Pharmacokinetics and Biopharmaceutics, 23, 267-286
72. Lokind, K. and Lorenzen, F., 1996. Oral bioavailability of 17β-estradiol and prodrugs tested in rats, pigs and dogs. International Journal of Pharmaceutics, 127, 155-164
73. Martis, L. and Levy, R., 1973. Bioavailability calculations for drugs showing simultaneous first-order and capacity limited elimination kinetics. Journal of Pharmacokinetics and Biopharmaceutics, 1, 283-294
74. Mayersohn, M., 1996. Principles of drug absorption. In: G. Banker and C. Rhodes (eds), Modern Pharmaceutics, 3rd edn, (Marcel Dekker, New York), 21-73
75. McKellar, Q., Galbraith, E. and Baxter, P., 1993. Oral absorption and bioavailability of fenbendazole in the dog and the effect of concurrent ingestion of food. Journal of Veterinary Pharmacology and Therapeutics, 16, 189-198
76. Melander, A., 1978. Influence of food on the bioavailability of drugs. Clinical Pharmacokinetics, 3, 337-351
77. Meyer, I. and Carlson, A., 1917. Contributions to the physiology of the stomach XLIII. Hunger and appetite in fever. American Journal of Physiology, 44, 222-233
78. Meyer, J., Dressman, J., Fink, A. and Amidon, G., 1985. Effect of size and density on canine gastric emptying of nondigestible solids. Gastroenterology, 89, 805-813
79. Minami, H. and McCallum, R., 1984. The physiology and pathophysiology of gastric emptying in humans. Gastroenterology, 86, 1592-1610
80. Muranishi, S., 1985. Modification of intestinal absorption of drug by lipoidal adjuvants. Pharmaceutical Research, 2, 108-118
81. Muranishi, S., 1990. Absorption enhancers. Critical Reviews in Therapeutic Drug Carrier Systems, 7, 1-33
82. Murata, K., Noda, K., Kohno, K. and Samejima, M., 1988. Bioavailability and pharmacokinetics of oral dopamine in dogs. Journal of Pharmaceutical Sciences, 77, 565-568
83. Murata, K., Noda, K., Kohno, K. and Samejima, M., 1989. Bioavailability and pharmacokinetics of an oral dopamine prodrug in dogs. Journal of Pharmaceutical Sciences, 78, 812-814
84. Nakayoshi, T., Izumi, M. and Tatsuta, K., 1992. Effects of macrolide antibiotics on gastrointestinal motility in fasting and digestive states. Drugs in Experimental Clinical Research, 18, 103-109
85. Navia, M. and Chaturvedi, P., 1996. Design principles for orally bioavailable drugs. Drug Discovery Today, 1, 179-189
86. Niazi, S., Vishnupad, K. and Veng-Pedersen, P., 1983. Absorption and disposition characteristics of nitrofurantoin in dogs. Biopharmaceutics and Drug Disposition, 4, 213-223
87. Ogata, H., Aoyagi, N., Kaniwa, N., Kitaura, T., Ohki, T., Kitamura, K., Inoue, Y., Kitamura, M. and Sekine, N., 1985. Gastric acidity dependent bioavailability of cinnarizine from commercially available capsules in humans and its correlation with bioavailability in beagle dogs and with dissolution rate. Journal of Pharmacobio-Dynamics, 8, S144
88. Øie, S. and Jung, D., 1979. Bioavailability under variable renal clearance conditions. Journal of Pharmaceutical Sciences, 68, 128-129
89. Olkkola, K., Brunetto, A. and Mattila, M., 1994. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents. Clinical Pharmacokinetics, 26, 107-120
90. Pao, L., Zhou, S., Cook, C., Kararli, T., Kirchhoff, C., Truelove, J., Karim, A. and Fleisher, D., 1998. Reduced systemic availability of an antiarrhythmic drug, bidisomide, with meal co-administration: relationship with region-dependent intestinal absorption. Pharmaceutical Research, 15, 221-227
91. Pellegatti, M., Grossi, P., Ayrton, J., Evans, G. and Harker, A., 1990. Absorption, distribution and excretion of lacipidine, a dihydropyridine calcium antagonist, in rat and dog. Xenobiotica, 20, 765-777
92. Perucca, E., 1980. Plasma protein binding of phenytoin in health and disease: relevance to therapeutic monitoring. Therapeutic Drug Monitoring, 2, 331-344
93. Peeters, T., Matthijs, G., Depoortere, I., Cachet, T., Hoogmartens, J. and Vantrappen, G., 1989. Erythromycin is a motilin receptor agonist. American Journal of Physiology, 257 (3 Pt. 1), G470-G474
94. Peter, G., Niebch, G., Locher, M. and Borbe, H., 1991. Pharmacokinetic fate of the novel antihypertensive drug naftopidil. Arzneimittelforschung, 41, 924-931
95. Polk, R., Healy, D., Sahai, J., Drwal, L. and Pracht, E., 1989. Effect of ferrous sulfate and multivitamins with zinc on the absorption of norfloxacin in normal volunteers. Antimicrobial Agents and Chemotherapy, 11, 1841-1844
96. Polli, J., Bigora, S., Piscitelli, D., Straughn, A. and Young, D., 1996. 'Pavlovian' food effect on the enterohepatic recirculation of piroxicam. Biopharmaceutics and Drug Disposition, 17, 635-641
97. Rackley, R., Meyer, M. and Straughn, A., 1991. Circadian rhythm in theophylline disposition: simulations and observations in the dog. Journal of Pharmaceutical Sciences, 80, 824-829
98. Remon, J., Belpaire, F., Van Seerens, R. and Braeckman, P., 1983. Interaction of antacids with antiarrhythmics. V. Effect of aluminium hydroxide and magnesium oxide on the bioavailability of quinidine, procainamide and propranolol in dogs. Arzneimittelforschung, 33, 117-120
99. Rinetti, M., Ugolotti, G., Calbiani, B., Colombi Zinelli, L., Cisternino, M. and Papa, N., 1982. Antiinflammatory drugs and gastric emptying. A comparison between acetylsalicylic acid and carprofen. Arzneimittelforschung, 32, 1561-1563
100. Ritschel, W., 1986. Handbook of Basic Pharmacokinetics, 3rd edn, (Drug Intelligence Publications, Illinois)
101. Ritschel, W., Bykadi, G., Norman, E. and Lücker, P., 1980. Chronopharmacokinetics of pentazocine in beagle dogs. Arzneimittelforschung, 30, 1535-1538
102. Ritschel, W., Neub, M. and Denson, D., 1987. Meperidine pharmacokinetics following intravenous, peroral and buccal administration in beagle dogs. Methods and Findings in Experimental and Clinical Pharmacology, 9, 811-815
103. Robinson, E., Sams, R. and Muir, W., 1986. Barbiturate anesthesia in Greyhound and in mixed-breed dogs: comparative cardiopulmonary effects, anesthetic effects, and recovery rates. American Journal of Veterinary Research, 47, 2105-2112
104. Rubin, G., Waschek, J., Pond, S., Effeney, D. and Tozer, T., 1987. Concurrent intravenous administration of a labeled tracer to determine the oral bioavailability of a drug exhibiting Michaelis-Menten metabolism. Journal of Pharmacokinetics and Biopharmaceutics, 15, 615-631
105. Sagara, K., Nagamatsu, Y., Yamada, I., Kawata, M., Mizuta, H. and Ogawa, K., 1992. Bioavailability study of commercial sustained-release preparations of diclofenac sodium in gastrointestinal physiology regulated-dogs. Chemical and Pharmaceutical Bulletin, 40, 3303-3306
106. Sakashita, M., Mizuki, Y., Yamaguchi, T., Miyazaki, H. and Sekine, Y., 1993. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in dogs and monkeys. Arzneimittelforschung, 43, 864-866
107. Sako, K., Mizumoto, T., Kajiyama, A. and Ohmura, T., 1996. Influence of factors in gastrointestinal tract on acetaminophen release from controlled-release tablets in fasted dogs. International Journal of Pharmaceutics, 137, 225-232
108. Sams, R., Muir, W. and Detra, R., 1985. Comparative pharmacokinetics and anesthetic effects of methohexital, pentobarbital, thiamylal, and thiopental in Greyhound dogs and non-Greyhound, mixed-breed dogs. American Journal of Veterinary Research, 46, 1677-1683
109. Sarna, S., 1985. Cyclic motor activity, migrating motor complex: 1985. Gastroenterology, 89, 894-913
110. Schurizek, B., Kraglund, K., Andreasen, F., Jensen, L. and Juhl, B., 1988. Gastrointestinal motility and gastric pH and emptying following ingestion of diazepam. British Journal of Anesthesia, 61, 712-719
111. Sriwatanakul, K. and Weintraub, M., 1983. Understanding food-drug interactions. Comprehensive Therapeutics, 9, 6-11
112. Stavchansky, S. and McGinity, J., 1990. Bioavailability in tablet technology. In: H. Lieberman, L. Lachman and J. Schwartz (eds), Pharmaceutical Dosage Forms: Tablets, vol. 2, 2nd edn, (Marcel Dekker, New York), 349-570
113. Stephens, J., Woolson, R. and Cooke, R., 1976. Osmolyte and tryptophan receptors controlling gastric emptying in the dog. American Journal of Physiology, 231, 848-853
114. Tabibi, S. and Rhodes, C., 1996. Disperse systems. In: G. Banker and C. Rhodes (eds.), Modern Pharmaceutics, 3rd edn, (Marcel Dekker, New York), 299-332
115. Tanaka, T., Mizumoto, A., Haga, N. and Itoh, Z., 1997. A new method to measure gastric emptying in conscious dogs: a validity study and effects of EM523 and L-NNA. American Journal of Physiology, 272, G909-G915
116. Thorpe-Vargas, S. and Cargill, J., 1998. Providing for your puppy's medical needs. Dog World, 83, 52-57
117. Tokumura, T., Tsushima, Y., Tatsuishi, K., Kayano, M., Machida, Y. and Nagai, T., 1987. Enhancement of the oral bioavailability of cinnarizine in oleic acid in beagle dogs. Journal of Pharmaceutical Sciences, 76, 286-288
118. Toothaker, R. and Welling, P., 1980. The effect of food on drug bioavailability. Annual Reviews in Pharmacology and Toxicology, 20, 173-199
119. Tozer, T. and Rubin, G., 1988. Saturable kinetics and bioavailability determination. In: P.G. Welling and F. Tse (eds), Pharmacokinetics, (Marcel Dekker, New York), 473-513
120. Tsuchida, E., 1991. Macromolecular complexes and their dynamic interactions and electronic processes. In: E. Tsuchida (ed.), Macromolecular Complexes, (VCH, New York), 3-14
121. Vallès, J., Pruñonosa, J., Menargues, A., Nomen, M. and Obach, R., 1989. Pharmacokinetic profile of idazoxan in the beagle dog. Journal of Pharmacy and Pharmacology, 41, 384-387
122. Van Hoogdalem, E., De Boer, A. and Breimer, D., 1989. Intestinal drug absorption enhancement: an overview. Pharmacology and Therapeutics, 44, 407-443
123. Van Miert, A., 1990. Influence of febrile disease on the pharmacokinetics of veterinary drugs. Annales de Recherches Vétérinaires, 21 (supplement 1), 11S-28S
124. Veng-Pederson, P., 1985. Novel method of calculating absolute bioavailability in nonlinear pharmacoki-netics. Journal of Pharmaceutical Science, 74, 90-93
125. Waschek, J., Rubin, G., Tozer, T., Fielding, R., Couet, W., Effeney, D. and Pond, S., 1984. Dose-dependent bioavailability and metabolism of salicylamide in dogs. Journal of Pharmacology and Experimental Therapeutics, 230, 89-93
126. Waschek, J., Fielding, R., Pond, S., Rubin, G., Effeney, D. and Tozer, T., 1985. Dose-dependent sulfoconjugation of salicylamide in dogs: effect of sulfate depletion or administration. Journal of Pharmacology and Experimental Therapeutics, 234, 431-434
127. Watson, A., Emslie, D. and Martin, I., 1987a. Effect of different intervals between dosing and feeding on systemic availability of penicillin V in dogs. Journal of Veterinary Pharmacology and Therapeutics, 10, 90-95
128. Watson, A., Emslie, D. and Martin, I., 1987b. Systemic availability of penicillin V from six oral preparations in dogs. Journal of Veterinary Pharmacology and Therapeutics, 10, 180-183
129. 15N-labelled drug to healthy volunteers. British Journal of Clinical Pharmacology, 32, 573-579
130. Welling, P., 1977. Influence of food and diet on gastrointestinal drug absorption: a review. Journal of Pharmacokinetics Biopharmaceutics, 5, 291-334
131. Welling, P., 1988. Dosage routes, bioavailability, and clinical efficacy. In: P. Welling and F. Tse (eds), Pharmacokinetics, (Marcel Dekker, New York), 473-513
132. Williams, L., Davis, J. and Lowenthal, D., 1993. The influence of food on the absorption and metabolism of drugs. Clinical Nutrition, 77, 815-829
133. Wu, H., Evreux Gros, C. and Descotes, J., 1996. Diazinon toxicokinetics, tissue distribution and anticholinesterase activity in the rat. Biomedical and Environmental Sciences, 9, 359-369
134. Yang, J., Morris, M., Wong, K., Kucharczyk, N. and Sofia, R., 1992. Felbamate metabolism in pediatric and adult beagle dogs. Drug Metabolism and Disposition, 20, 84-88
135. Yoshimura, Y. and Kakeya, N., 1983. Structure-gastrointestinal absorption relationship of penicillins. International Journal of Pharmaceutics, 17, 47-57
136. Zoran, D., Riedesel, D. and Dyer, D., 1993. Pharmacokinetics of propofol in mixed-breed dogs and Greyhounds. American Journal of Veterinary Research, 54, 755-760